ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,825,090 | -64.7% | 492,924 | -74.1% | 0.20% | -55.2% |
| Q1 2023 | $10,845,065 | -3.2% | 1,902,643 | 0.0% | 0.46% | -2.8% |
| Q4 2022 | $11,206,567 | +84.1% | 1,902,643 | 0.0% | 0.47% | +86.2% |
| Q3 2022 | $6,088,000 | +7.6% | 1,902,643 | +50.7% | 0.25% | +17.7% |
| Q2 2022 | $5,656,000 | +140.4% | 1,262,464 | +186.5% | 0.22% | +198.6% |
| Q1 2022 | $2,353,000 | -63.7% | 440,696 | 0.0% | 0.07% | -42.4% |
| Q4 2021 | $6,478,000 | +107.8% | 440,696 | +195.6% | 0.12% | +135.8% |
| Q3 2021 | $3,118,000 | -63.6% | 149,100 | -41.0% | 0.05% | -56.6% |
| Q4 2020 | $8,561,000 | +232.1% | 252,910 | +230.9% | 0.12% | +121.8% |
| Q2 2020 | $2,578,000 | – | 76,432 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |